Citation Impact
Citing Papers
Human Hypertension Caused by Mutations in WNK Kinases
2001 StandoutScience
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Primary Prevention of Ischemic Stroke
2006
Antihypertensive drugs and risk of incident gout among patients with hypertension: population based case-control study
2012
Guidelines for the Primary Prevention of Stroke A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists.
2011
Gender differences in depression in representative national samples: Meta-analyses of diagnoses and symptoms.
2017 Standout
Resistant Hypertension
2008
Alterations in cardiac adrenergic signaling and calcium cycling differentially affect the progression of cardiomyopathy
2001 StandoutNobel
A Systematic Comparison of the Properties of Clinically Used Angiotensin II Type 1 Receptor Antagonists
2013
Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study
2009 Standout
Molecular genetics of human hypertension
1998
Effects of Dietary Sodium and Hydrochlorothiazide on the Antiproteinuric Efficacy of Losartan
2008
Molecular genetics of human hypertension
2000
Telmisartan
2001
Chronic inflammation in the etiology of disease across the life span
2019 Standout
Prognostic Effect of Exercise Capacity on Mortality in Older Adults with Diabetes Mellitus
2010
Ubiquitin Ligase Nedd4L Targets Activated Smad2/3 to Limit TGF-β Signaling
2009
Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension
2010 Standout
TGFβ signalling in context
2012 Standout
Molecular Mechanisms of Human Hypertension
2001 Standout
Cellular pathophysiology of ischemic acute kidney injury
2011 Standout
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
2003 Standout
Exercise Standards for Testing and Training
2013 Standout
Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents
2017 Standout
Physical Activity and Cardiorespiratory Fitness as Major Markers of Cardiovascular Risk: Their Independent and Interwoven Importance to Health Status
2014
Guidelines for the Primary Prevention of Stroke
2010
Gout
2009 Standout
Chronic kidney disease
2011 Standout
2007 Guidelines for the Management of Arterial Hypertension
2007 Standout
Interactive effects of fitness and statin treatment on mortality risk in veterans with dyslipidaemia: a cohort study
2012
Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association
2021 Standout
Lack of Exercise Is a Major Cause of Chronic Diseases
2012 Standout
US Trends in Prevalence, Awareness, Treatment, and Control of Hypertension, 1988-2008
2010 Standout
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
2013 Standout
Gout
2016 Standout
Treatment of Hypertension in Patients 80 Years of Age or Older
2008 Standout
Effect of Physical Activity Assessment on Prognostication for Peripheral Artery Disease and Mortality
2015
Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels
2013 StandoutNobel
Even a low-dose of moderate-to-vigorous physical activity reduces mortality by 22% in adults aged ≥60 years: a systematic review and meta-analysis
2015
Heart Rate, Life Expectancy and the Cardiovascular System: Therapeutic Considerations
2015 Standout
Improved Reclassification of Mortality Risk by Assessment of Physical Activity in Patients Referred for Exercise Testing
2014
Reporting of Noninferiority and Equivalence Randomized Trials
2012 Standout
Special Invited Papers Section: Therapeutic Equivalence – Clinical Issues and Statistical Methodology in Noninferiority Trials
2005
Atherosclerosis
2000 StandoutNature
Genome-wide association studies for common diseases and complex traits
2005 Standout
Genetic Factors in Hypertension – What is Known and What Does It Mean?
2001
Transition‐Metal‐Catalyzed Direct Arylation of (Hetero)Arenes by CH Bond Cleavage
2009 Standout
Uricosuric Action of Losartan via the Inhibition of Urate Transporter 1 (URAT 1) in Hypertensive Patients
2008
Human genetics, animal models and computer simulations for studying hypertension☆
2004 StandoutNobel
Prediction of Cardiovascular Events and All-Cause Mortality With Arterial Stiffness
2010 Standout
Redox Signaling, Vascular Function, and Hypertension
2008
Blood pressure abnormalities in children with sickle cell anemia
2013
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
Expression of a β-adrenergic receptor kinase 1 inhibitor prevents the development of myocardial failure in gene-targeted mice
1998 StandoutNobel
Aerobic interval training reduces blood pressure and improves myocardial function in hypertensive patients
2011
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
Analysis of the Structural Diversity, Substitution Patterns, and Frequency of Nitrogen Heterocycles among U.S. FDA Approved Pharmaceuticals
2014 Standout
Primary Prevention of Ischemic Stroke
2001
Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial
2010 Standout
Importance of Assessing Cardiorespiratory Fitness in Clinical Practice: A Case for Fitness as a Clinical Vital Sign: A Scientific Statement From the American Heart Association
2016 Standout
Exercise and Physical Activity
2010
Guidelines for the Primary Prevention of Stroke
2014 Standout
Genes and Hypertension
2000
Body Mass Index and Sexual Dysfunction in Males and Females in a Population Study
2013
Genomic predictors of the maximal O2 uptake response to standardized exercise training programs
2010
Exercise capacity and haemodynamic response among 12,327 individuals with cardio-metabolic risk factors undergoing treadmill exercise
2017
Lifetime sedentary living accelerates some aspects of secondary aging
2011
Resistant Hypertension: Diagnosis, Evaluation, and Treatment
2008
Evidence for a Gene Influencing Blood Pressure on Chromosome 17
2000
Restoration of β-adrenergic signaling in failing cardiac ventricular myocytes via adenoviral-mediated gene transfer
1997 StandoutNobel
Gout
2021 Standout
Heritability of Ischemic Stroke in Relation to Age, Vascular Risk Factors, and Subtypes of Incident Stroke in Population-Based Studies
2004
Sex Differences in Heritability of Ischemic Stroke
2007
Primary Prevention of Ischemic Stroke
2001
Exercise Capacity and All-Cause Mortality in Male Veterans With Hypertension Aged ≥70 Years
2014
Cardiac βARK1 inhibition prolongs survival and augments β blocker therapy in a mouse model of severe heart failure
2001 StandoutNobel
Particulate Matter Air Pollution and Cardiovascular Disease
2010 Standout
Current Guidelines for Using Angiotensin-Converting Enzyme Inhibitors and Angiotensin II–Receptor Antagonists in Chronic Kidney Disease: Is the Evidence Base Relevant to Older Adults?
2009
Parental Occurrence of Stroke and Risk of Stroke in Their Children
2010
Systematic Review of Methods and Results of Studies of the Genetic Epidemiology of Ischemic Stroke
2003
Abdominal Visceral and Subcutaneous Adipose Tissue Compartments
2007 Standout
An Updated Definition of Stroke for the 21st Century
2013 Standout
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
Preservation of myocardial β-adrenergic receptor signaling delays the development of heart failure after myocardial infarction
2000 StandoutNobel
The Future of Aerobic Exercise Testing in Clinical Practice: is It the Ultimate Vital sign?
2010
Pharmacogenomics of hypertension.
2003
Resistant Hypertension: Diagnosis, Evaluation, and Treatment
2008 Standout
Works of Athanasios Manolis being referenced
Statin Therapy, Fitness, and Mortality Risk in Middle-Aged Hypertensive Male Veterans
2014
Sexual dysfunction: the ‘prima ballerina’ of hypertension-related quality-of-life complications
2008
Angiotensin II receptor antagonist telmisartan in isolated systolic hypertension (ARAMIS) study
2004
The angiotensin II receptor antagonist telmisartan reduces urinary albumin excretion in patients with isolated systolic hypertension: results of a randomized, double-blind, placebo-controlled trial
2005
Comparison of antihypertensive effects of an angiotensin-converting enzyme inhibitor, a calcium antagonist and a diuretic in patients with hypertension not controlled by angiotensin receptor blocker monotherapy
2005
Effects of losartan and candesartan monotherapy and losartan/hydrochlorothiazide combination therapy in patients with mild to moderate hypertension
2000
The J-Curve in Arterial Hypertension: Fact or Fallacy?
2014
Polymorphisms in the Promoter Region of Catalase Gene and Essential Hypertension
2005
Maternal component in the familial aggregation of hypertension
2001
Genetic epidemiology of essential hypertension
1999
Genetic Predisposition to Stroke in Relatives of Hypertensives
2000
A graded association of exercise capacity and all-cause mortality in males with high-normal blood pressure
2009
Evidence for Linkage Between Essential Hypertension and a Putative Locus on Human Chromosome 17
1999
Exercise Capacity and Mortality in Hypertensive Men With and Without Additional Risk Factors
2009
Physical activity in the prevention and management of high blood pressure.
2009
Comparative Prognostic Role of Nighttime Blood Pressure and Nondipping Profile on Renal Outcomes
2011
Exercise Capacity and Mortality in Older Men
2010
Association of NEDD4L Ubiquitin Ligase With Essential Hypertension
2005